CLINICAL_TRIALS
trial_result
· 2024-01-24
Clinical Trial Update: Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy [Phase 1]
Summary
Phase 1 pharmacology study evaluating oral edaravone in amyotrophic lateral sclerosis patients with gastrostomy; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma Corporation | Conditions: Japanese Patients With ALS | Phase 1 | Status: COMPLETED | Results posted: 2024-01-24